Application of acetyl coenzyme A carboxylase gene in regulation of pig fat metabolism
By inhibiting the expression of acetyl-CoA carboxylase gene, promoting pig fat burning and beige fat production, the problem of insufficient fat deposition and cold resistance of pigs is solved, effective obesity treatment and livestock breeding are achieved, and existing weight loss drugs are avoided. The shortcomings.
Patent Information
- Application Number
- CN202411399340.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-09
- Publication Date
- 2024-11-08
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The prior art is difficult to effectively promote pig beige fat production, resulting in insufficient fat deposition and cold resistance of pigs, and insufficient effectiveness of existing weight loss drugs and doubts about safety.
By inhibiting the expression of acetyl-CoA carboxylase (ACACA) gene, inhibitors such as siRNA, shRNA, and TOFA are used to promote pig fat burning and beige fat production, and are used in obesity treatment, weight loss and livestock and poultry breeding.
It has successfully promoted pig fat burning, reduced fat deposition, enhanced cold resistance, and provided new solutions for obesity treatment and livestock breeding, avoiding the insufficient effectiveness and doubtful safety of existing weight loss drugs.
Smart Images

Figure FT_1 
Figure FT_2 
Figure SMS_4
Abstract
Description
Technical Field
[0001] The invention relates to the field of biotechnology, in particular to the application of acetyl-CoA carboxylase gene in regulating pig fat metabolism. Background Art
[0002] Adipose tissue plays a key role in maintaining the body's energy balance and is mainly divided into white fat that stores energy and brown fat that has a heat-generating function. Beige fat transforms from white fat to brown fat-like functions after being activated by cold or beta-adrenaline, enhancing energy consumption. Studies have shown that inducing beige fat production can reduce fat deposition and resist obesity.
[0003] As an important source of meat, pig fat deposition has a direct impact on meat quality, yield and cold tolerance. However, since pigs lack UCP1 and classic brown fat, research has focused on exploring the relationship between beige fat production and fat deposition traits. Cold-resistant pig breeds, such as Tibetan pigs and Northeast Min pigs, have stronger cold resistance by producing beige fat cells. Therefore, discovering the key genes that promote beige fat formation in pigs is of great significance for improving their fat traits.
[0004] ACACA is the rate-limiting enzyme for fatty acid synthesis and is mainly expressed in high lipid-producing tissues such as adipose tissue. Inhibition of ACACA can promote beige adipogenesis by reducing fatty acid synthesis, thereby reducing fat deposition and enhancing thermogenesis. Therefore, the application of ACACA gene and its inhibitor in the regulation of pig fat metabolism has potential value and can serve as a new target for feed additives in molecular breeding and production. Summary of the invention
[0005] The purpose of the present invention is to provide the application of acetyl-CoA carboxylase (ACACA) gene in regulating pig fat metabolism.
[0006] In order to achieve the purpose of the present invention, in a first aspect, the present invention provides the use of acetyl-CoA carboxylase gene in regulating pig fat metabolism, inhibiting the expression of pig acetyl-CoA carboxylase gene and promoting fat burning.
[0007] Preferably, the nucleotide sequence of the coding region of the ACACA gene is as shown in SEQ ID NO:1.
[0008] Preferably, the amino acid sequence of the protein (porcine acetyl-CoA carboxylase) encoded by the ACACA gene is shown in SEQ ID NO: 2.
[0009] In a second aspect, the present invention provides an application of the acetyl-CoA carboxylase gene in regulating beige fat production in pigs, inhibiting the expression of the acetyl-CoA carboxylase gene in pigs and promoting beige fat production.
[0010] In a third aspect, the present invention provides any of the following uses of acetyl-CoA carboxylase gene inhibitors: 1) For the preparation of products for the treatment and / or prevention of obesity; 2) Used to promote the burning of white fat cells; 3) Used to prepare products that promote weight loss; 4) Used to inhibit subcutaneous and / or intra-abdominal white fat accumulation / accumulation; 5) Used for breeding low-fat livestock and poultry breeds; 6) Used for breeding cold-resistant livestock and poultry breeds.
[0011] The inhibitor can be selected from shRNA, siRNA, dsRNA, miRNA, cDNA, antisense RNA / DNA, low molecular weight compounds, Cre-Loxp, TALEN, ZFN or CRISPR / Cas9, etc.
[0012] Preferably, the inhibitor is siRNA, the sequence of which is shown in SEQ ID NO: 3, and the base sequence thereof is a nucleotide sequence that is reverse complementary to bases 1741-1761 of the ACACA gene coding region of SEQ ID NO: 1.
[0013] More preferably, the two bases U at the 3'-end of the siRNA sequence can be replaced by T (ie, GCUUCUGUCAGCUCAGAUATT), which does not affect the inhibitory effect, reduces costs, and can also enhance the ability to resist enzyme degradation.
[0014] Preferably, the inhibitor is shRNA, and the DNA sequence encoding the shRNA is shown in SEQ ID NO:4, wherein the bases of the targeting sequence are the same as bases 3349-3369 of the ACACA gene coding region of SEQ ID NO:1.
[0015] Preferably, the inhibitor is 5-(Tetradecyloxy)-2-furoic acid (TOFA).
[0016] By means of the above technical solution, the present invention has at least the following advantages and beneficial effects: (A) This invention reveals for the first time that the ACACA gene is involved in regulating the production of beige fat.
[0017] (ii) The present invention clarifies that inhibiting ACACA gene expression can directly promote in vivo fat burning.
[0018] (III) The present invention provides a new solution for treating obesity and obesity-related diseases, avoiding the problems of insufficient effectiveness and questionable safety of weight loss drugs.
[0019] (iv) The present invention provides a new approach for breeding cold-resistant, low-fat livestock and poultry breeds. BRIEF DESCRIPTION OF THE DRAWINGS
[0020] Figure 1 In a preferred embodiment of the present invention, the expression of ACACA gene regulates thermogenesis in Tibetan pig adipocytes. (A) Fluorescence staining images of cells treated with FSK and TOFA, BODIPY staining shows lipid droplets, TMRE staining shows mitochondrial membrane potential of differentiated adipocytes, scale bar is 10μM; (B) Effects of FSK and TOFA treatment on mitochondrial respiration of differentiated adipocytes of Tibetan pigs, FSK, TOFA alone or combined stimulation (n=5); (C) Immunohistochemistry results of PRDM16, pHSL and HSL (n=3); (D-E) Protein and mRNA expression levels of beige adipocyte molecular markers in differentiated adipocytes of Tibetan pigs, FSK, TOFA alone or combined stimulation (n=6) (F) Protein expression and Oil Red O staining of cells overexpressing and knocking down ACACA; (G) Seahorse determination of mitochondrial respiration of Tibetan pig adipocytes after shRNA transfection (n=5); (H) Basal respiration and proton leak calculated by G-graph results (n=5); (I) Seahorse determination of mitochondrial respiration of Tibetan pig adipocytes after overexpression of ACACA (n=5) ; (J) Basal respiration and proton leak calculated from the results of Figure I (n=5); (K) Seahorse measurement of mitochondrial respiration in Tibetan pig adipocytes after siRNA transfection (n=5); (L) Basal respiration and proton leak calculated from the results of Figure K (n=5).
[0021] In the figure, P<0.05, P<0.01, P<0.001.
[0022] Figure 2 This is the plasmid map of the ACACA overexpression vector in the preferred embodiment of the present invention. DETAILED DESCRIPTION
[0023] Research has found that ACACA is a new and important beige fat metabolism regulatory molecule. The reduction of its protein level can promote beige fat heat production and burn white fat, thereby improving the body's cold resistance and reducing the body's white fat content. Based on this, the present invention focuses on the application of inhibiting ACACA protein or gene in the preparation of slimming and weight loss products, improving the cold resistance of livestock and poultry, and reducing the fat content of livestock and poultry in the selection of high-quality varieties.
[0024] The present invention adopts the following technical solution: The present invention provides an application of an agent for inhibiting ACACA gene expression in preparing a product having at least one of the following functions 1)-6): 1) Treat and / or prevent obesity; 2) Promote the burning of white fat cells; 3) Promote weight loss; 4) Inhibit subcutaneous and / or intra-abdominal white fat accumulation / accumulation; 5) Used for breeding low-fat livestock and poultry breeds; 6) Used for breeding cold-resistant livestock and poultry breeds.
[0025] Preferably, the nucleotide sequence of the coding region of the ACACA gene is as shown in SEQ ID NO:1.
[0026] Preferably, the amino acid sequence of the protein encoded by the ACACA gene is shown in SEQ ID NO:2.
[0027] Preferably, the siRNA of the ACACA gene has a sequence as shown in SEQ ID NO:3, and its base sequence is a nucleotide sequence that is reverse complementary to bases 1741-1761 of the ACACA gene coding region of SEQ ID NO:1.
[0028] More preferably, the two bases U at the 3'-end of the siRNA sequence can be replaced by T (ie, GCUUCUGUCAGCUCAGAUATT), which does not affect the inhibitory effect, reduces costs, and can also enhance the ability to resist enzyme degradation.
[0029] Preferably, the shRNA of the ACACA gene, the DNA sequence encoding the shRNA is shown in SEQ ID NO:4, wherein the bases of the targeting sequence are the same as bases 3349-3369 of the ACACA gene coding region of SEQ ID NO:1.
[0030] Preferably, the full sequence of the ACACA overexpression vector is composed of SEQ ID NOs: 5 and 6 in series.
[0031] Preferably, the agent for inhibiting the expression of the ACACA gene is an antisense nucleic acid or an inhibitory transcription factor.
[0032] Preferably, the agent for inhibiting ACACA gene expression comprises Cre-Loxp, TALEN, ZFN or CRISPR / Cas9.
[0033] Preferably, the agent is capable of silencing or knocking out the gene of ACACA.
[0034] The following examples are used to illustrate the present invention, but are not intended to limit the scope of the present invention. Unless otherwise specified, the technical means used in the examples are conventional means well known to those skilled in the art, and the raw materials used are all commercially available products.
[0035] Example 1 ACACA inhibitor TOFA enhances thermogenesis in pig adipocytes To detect whether inhibition of ACACA regulates the thermogenic process of porcine adipocytes, stromal vascular fraction (sVF) cells were isolated from Tibetan pig cells, and SVF cells were induced to differentiate into adipocytes. A cell permeability inhibitor TOFA was used to inhibit the activity of ACACA to analyze whether the thermogenic process of porcine adipocytes was affected.
[0036] 1. Isolation of porcine adipose stromal vascular fraction (SVF) Subcutaneous adipose tissue (SAT) of 5-week-old male Tibetan pigs and Bama pigs was surgically removed and minced into small pieces. 2 mg / ml Type I collagenase was used for enzymatic digestion in D-Hanks buffer at 37°C for 60 minutes, and then undigested tissue was removed by filtration through a 70 μM filter. The filtrate was centrifuged at 1500 r / min for 10 minutes to collect the SVF cell pellet, remove the red blood cells and centrifuge again. SVF cells were suspended in DMEM / F12 medium containing 10% fetal bovine serum and 1% penicillin-streptomycin and cultured in an incubator at 38.5°C and 5% CO2.
[0037] 2. Adipogenic differentiation of porcine SVF cells SVF cells were seeded on culture plates until confluence and cultured for another 2 days (D0). The culture medium was replaced with an induction medium (containing 0.25 mM IBMX (3-isobutyl-1-methylxanthine), 1 μM dexamethasone, 5 μg / mL insulin, 17 μM pantothenic acid, 33 μM biotin, and 50 μM rosiglitazone) and cultured for 5 days. The culture medium was then replaced with a maintenance medium (containing 5 μg / mL insulin, 17 μM pantothenic acid, and 33 μM biotin) and cultured until day 8.
[0038] 3. Experiment on the inhibition of ACACA in pig adipocytes by TOFA In the differentiated adipocytes on the 8th day, each experimental group was treated as follows: control group: no drug intervention, only the carrier solution was added; TOFA treatment group was treated with 10μM TOFA for 24 hours; FSK (forskolin, induces the formation of intracellular cAMP, stimulates fat hydrolysis and mitochondrial respiration) treatment group was treated with 10μM FSK for 24 hours; combined treatment group was treated with 10μM TOFA and 10μM FSK for 24 hours.
[0039] 4. Cell fluorescence staining The SVF cells of Tibetan pigs were inoculated in 35 mm glass-bottomed dishes and induced to differentiate. After differentiation and maturation, they were washed twice with preheated DPBS, and DMEM complete medium containing 200 nM BODIPY493 / 503 and 20 nM tetramethylrhodamine, ethyl ester (TMRE) was added. The cells were stained in a 37°C cell culture incubator for 15-30 minutes, and photographed with a laser confocal microscope. BODIPY493 / 503 can dye lipid droplets green, and TMRE is a red dye that dyes mitochondrial membrane potential.
[0040] 5. Seahorse XF Energy Metabolism Detection System detects mitochondrial respiratory function SVF cells from Tibetan pigs were inoculated into XF24 cell culture plates, with 80-100 μL of cell suspension in each well. After the cells settled, they were placed in a 37°C, 5% CO2 incubator for culture and differentiation induction. Differentiated cells on day 8 were used for detection. The day before the experiment, 200 μL of sterile water was added to each well of the probe plate and hydrated overnight in a 37°C, CO2-free incubator. On the day of the experiment, the sterile water in the probe plate was discarded, and 200 μL of XF calibrant (Agilent, 103575-100) was added, and equilibrated in a 37°C, CO2-free incubator for 45-60 minutes. At the same time, the detection solution was prepared (1 mL 1 M glucose, 1 mL 100 mM pyruvate and 1 mL 200 mM glutamine were added to 100 mL seahorse XF DMEM medium), and 1.5 μM oligomycin, 0.5 μM uncoupler (FCCP) and 0.5 μM rotenone / antimycin A (Rot / AA) 10× drug solution was prepared. The cell plate was aspirated and the medium was washed twice with 200 μL of detection solution. Finally, 160 μL of detection solution was added to each well, and the total volume was 180 μL. After equilibration in a 37°C, CO2-free incubator for 45-60 minutes, the detection was performed. The basal respiration, maximum respiration rate and proton leak were measured by Wave software, and the data analysis was normalized by the DNA or protein content in each well.
[0041] 6. qPCR analysis Total RNA was extracted from adipose tissue of Bama piglets (TRIzol reagent, Thermo Fisherscientific, 15596018) and purified according to the manufacturer's instructions. 1 μg of total RNA was reverse transcribed into cDNA (PrimeScript™ RT kit, Takara, RR047A) and quantitative PCR analysis was performed on a QuantStudio 3 Real-Time PCR System (Life Technologies) using TB Green Premix Ex Taq (Takara, RR420A) to analyze beige adipocyte marker genes PRDM16, EBF2, DIO2, UCP3, and CIDEA, with 18S rRNA (Gene ID: 100861538) as an internal reference gene for normalization. The primer sequences are shown in Table 1.
[0042] Table 1 Primer sequences for fluorescence quantitative PCR
[0043] 7. Immunoblotting analysis Cell lysates (100 μL each) were extracted using M-PERTM mammalian protein extraction reagent (Thermo Fisherscientific, 78503) and supplemented with a protease inhibitor cocktail (Roche, 04693159001). After centrifugation (12,000 × g, 4°C, 20 min), the obtained proteins (20–50 μg) were separated by 10% sDS-polyacrylamide gel electrophoresis and transferred to a PVDF membrane (Merck-Millipore, IPVH00010). Primary antibodies (such as PRDM16 and HSL) were used for detection, and the immunoreactive bands were visualized using the FluorChem M fluorescence imaging system (Tanon, 5200) and ECL developer (Tanon, 180–501).
[0044] Research results: TOFA is an allosteric inhibitor of ACACA that can inhibit fatty acid synthesis. From the results of fluorescent staining, it can be found that FSK treatment promotes lipid droplet hydrolysis and the number of small lipid droplets increases significantly. Although there are still many large lipid droplets in the cells treated with TOFA, many tiny lipid droplets appear. When FSK and TOFA are treated at the same time, all large lipid droplets are hydrolyzed into small lipid droplets and micro lipid droplets ( Figure 1 A). We examined the effects of FSK and TOFA treatment on cell OCR ( Figure 1 B) The results showed that both FSK and TOFA significantly increased proton leak respiration and reduced ATP production, and the proton leak was the highest in the group treated with both FSK and TOFA ( Figure 1C). In addition, we found that both FSK and TOFA treatment increased thermogenesis genes PRDM16, EBF2, PPARGC1A, CPT1A and DIO2 The expression levels of these thermogenic genes were the highest in the FSK and TOFA treatment groups ( Figure 1 , DE). These results suggest that using TOFA to inhibit the activity of ACACA can not only enhance thermogenesis in pig adipocytes, but also further enhance thermogenesis induced by FSK.
[0045] Example 2 Overexpression or inhibition of ACACA gene to regulate thermogenesis in Tibetan pig adipocytes In addition to using the small molecule inhibitor TOFA of ACACA to study its regulatory effect on adipocyte thermogenesis, we also used genetic methods to detect the regulatory effect of the ACACA gene on pig adipocyte thermogenesis, including overexpression or knockdown of the expression of the ACACA gene.
[0046] 1. RNA interference (1) Find the mRNA sequence of the gene through the NCBI website, use the online website siDirect version 2.0 (http: / / sidirect2.rnai.jp / design.cgi) to design siRNA, and select the top three sequences to have Shanghai Jima Biotechnology Company synthesize siRNA sequences and negative control sequences; (2) SVF cells were plated into a 12-well cell culture plate. When the cells grew to 70-80%, the culture medium was aspirated and 875 μL of DMEM complete culture medium was added to each well. The plate was then placed in a cell culture incubator. (3) Prepare interference reagents according to the number of cells to be treated in the cell culture plate. Solution A: add 62.5 μL of OPTI and 2.5 μL of siRNA or negative control to each well. Solution B: add 62.5 μL of OPTI-MEM™ serum-free medium and 2.5 μL of RNAIMAX transfection reagent to each well. Mix solution A and solution B separately and let stand at room temperature for 5 minutes. (4) Add solution B to solution A, mix thoroughly, and incubate at room temperature for 15 min. (5) Slowly add the above mixed solution to the cell culture plate at a rate of 125 μL per well, gently mix the culture medium and interfering reagent in the cell culture plate, and place it in a cell culture incubator; (6) On the 0th and 3rd day of cell differentiation induction, the cells were treated again according to the above steps, and the DMEM complete medium was replaced with a medium containing differentiation induction reagents.
[0047] 2. Construction of shRNA and overexpression plasmids (1) shRNA design: Using the CDS region of the porcine ACACA gene (NCBI number NM_001114269.1) as a template, shRNA was designed using an online website (https: / / portals.broadinstitute.org / gpp / public). The top three shRNA sequences were selected, and the primers were annealed and ligated to the digested plasmid (PB-pACACA-shRNA). The ligase system is shown in Table 2. Construction of overexpression plasmid: The CDS region of the ACACA gene was amplified using Tibetan pig cDNA as a template, and the ACACA gene was connected to the enzyme-cut plasmid (PB513B-1-CAG) to construct the overexpression plasmid (the full sequence of the overexpression plasmid is shown in SEQ ID NO: 5 and 6); Table 2 Ligase system
[0048] (2) The ligated plasmid ( Figure 2 ), add 50 μL of E. coli DH5α competent cells, flick the bottom of the centrifuge tube to mix, and place on ice for 30 min; (3) Heat shock at 42°C for 30 seconds, quickly insert into ice, let stand for 2 minutes, add to 500 μL LB medium, and shake at 200 rpm in a 37°C incubator for 1 hour; (4) Centrifuge at 3000 rpm for 2 min, discard the supernatant, and keep about 100 μL to resuspend the E. coli precipitate at the bottom; (5) Plate coating: Evenly coat all 100 μL of the above bacterial solution on the plate containing ampicillin resistance, place it upright in a 37°C incubator for 1 hour, then invert it and culture overnight; (6) Bacterial selection: For each plasmid, pick 10-15 colonies and place them in 5 mL of LB liquid medium containing ampicillin. Shake at 200 rpm at 37°C for 5-6 h. When the bacterial solution becomes turbid, take 500 μL of the bacterial solution for sequencing. (7) The plasmid with the correct sequencing result is inoculated into 200 mL of LB liquid culture medium and cultured for 12-16 hours. The plasmid is extracted according to the instructions of the plasmid extraction kit and sequenced. The plasmid with the correct sequence can be used to transfect cells.
[0049] 3. Cell transfection and screening (1) Tibetan pig SVF cells were cultured in a 100 mm culture dish and electroporated when they grew to about 80-90%; (2) Add 1 mL of culture medium to a 12-well plate and place it in a cell culture incubator for CO2 balance; (3) Wash the cells with DPBS, digest the cells with 0.25% trypsin, and centrifuge at 80 g for 10 min. (4) Prepare electroporation solution during centrifugation. Use 100 μL electroporation solution for each plasmid. Take 10 μL to dilute the plasmid. Calculate the amount of electroporation based on the molar mass ratio of the plasmid. (5) After the cells are centrifuged, aspirate the supernatant, gently disperse the precipitate by hand, gently resuspend the cell precipitate with 90 μL of electroporation buffer, mix with the plasmid, and transfer all of it into the electroporation cup; (6) Gently shake the electroporation cup on the table for a few times, put it into the electroporator, and start electroporation; (7) Take out the 12-well plate that has been equilibrated with CO2 from the incubator, use a Pasteur pipette to draw 500 μL of culture medium and mix it with the cells in the electroporation cup, and then add 5×10 5 Pieces / hole planking; (8) 24 hours after electroporation, replace the culture medium with complete medium and observe the transfection efficiency under an inverted fluorescence microscope; (9) After 48 hours, switch to complete culture medium containing 2 mg / mL puromycin. Change the medium every 2 days until all cells are successfully electroporated. Then proceed to subsequent experiments or freeze the cells.
[0050] 4. Red O staining and quantification (1) After inducing differentiated mature cells, discard the culture medium, wash twice with preheated DPBS, and add 4% paraformaldehyde to fix for 30-60 minutes; (2) Prepare Oil Red O working solution by mixing Oil Red O stock solution with distilled water in a ratio of 3:2, filter with a 0.45 μM filter, and let stand at room temperature in the dark for 5-10 minutes before use; (3) After the cells are fixed, discard the 4% paraformaldehyde and wash them once with distilled water and then with 60% isopropanol; (4) Add 2-3 mL (taking a six-well plate as an example) of Oil Red O working solution to each well and stain at room temperature in the dark for 15-30 minutes; (5) Aspirate and discard the Oil Red O working solution, wash away the excess Oil Red O working solution with 60% isopropanol, wash the cells with distilled water, add 1 mL of distilled water to each well, and take pictures with an inverted microscope; (6) Quantification of Oil Red O: Aspirate the distilled water, add 1 mL of 100% isopropanol to each well, place on a shaker, shake at room temperature for 10 min, pipette 200 μL from each well into a 96-well plate, and measure the absorbance at 510 nM using an ELISA reader.
[0051] Research results: By detecting the expression level of ACACA protein in differentiated and mature adipocytes, it was found that the ACACA protein in the gene overexpression (OE) group was significantly increased, and the ACACA protein expression in the gene knockdown (shRNA) group was significantly decreased ( Figure 1F). Oil red O staining results showed that ACACA gene overexpression increased lipid accumulation, while gene knockdown significantly inhibited lipid accumulation ( Figure 1 F). To explore ACACA The effects of gene knockdown and overexpression on thermogenesis in pig adipocytes were investigated by measuring mitochondrial respiration of cells. The results showed that stable knockdown of ACACA expression by shRNA significantly enhanced the proton leak respiration of cells, and the corresponding oxygen consumption for ATP production decreased, indicating enhanced thermogenesis ( Figure 1 , GH). In contrast, overexpression of ACACA significantly inhibited the proton leak respiration of cells, suggesting that heat production was inhibited ( Figure 1 , IJ). Further knockdown of ACACA expression by siRNA during pig adipocyte differentiation also revealed that proton leak respiration in pig adipocytes was significantly enhanced and ATP production respiration was reduced ( Figure 1 , KL), confirmed that inhibition of ACACA can promote thermogenesis in adipocytes.
[0052] Although the present invention has been described in detail above with general descriptions and specific embodiments, it is obvious to those skilled in the art that some modifications or improvements can be made based on the present invention. Therefore, these modifications or improvements made without departing from the spirit of the present invention all fall within the scope of protection claimed by the present invention.
Claims
1. The use of acetyl-CoA carboxylase gene in regulating pig fat metabolism, characterized in that: Inhibit the gene expression of porcine acetyl-CoA carboxylase and promote fat burning; Among them, the amino acid sequence of porcine acetyl-CoA carboxylase is shown in SEQ ID NO:
2.
2. The use of acetyl-CoA carboxylase gene in regulating beige fat production in pigs, characterized in that: Inhibits the gene expression of porcine acetyl-CoA carboxylase and promotes beige fat production; Among them, the amino acid sequence of porcine acetyl-CoA carboxylase is shown in SEQ ID NO:
2.
3. Any of the following uses of acetyl-CoA carboxylase gene inhibitors: 1) For the preparation of products for the treatment and / or prevention of obesity; 2) Used to promote fat cell burning; 3) Used to prepare products that promote weight loss; 4) Used to inhibit subcutaneous and / or intra-abdominal white fat accumulation / accumulation; 5) Used for breeding low-fat livestock and poultry breeds; 6) Used for breeding cold-resistant livestock and poultry varieties; in, The amino acid sequence of porcine acetyl-CoA carboxylase is shown in SEQ ID NO: 2; The inhibitor is selected from shRNA, siRNA, dsRNA, miRNA, cDNA, antisense RNA / DNA, low molecular weight compounds, Cre-Loxp, TALEN, ZFN or CRISPR / Cas9.
4. The use according to claim 3, characterized in that: The inhibitor is siRNA, and the sequence is shown in SEQ ID NO:
3.
5. The use according to claim 3, characterized in that: The inhibitor is shRNA, and the DNA sequence encoding the shRNA is shown in SEQ ID NO:
4.
6. The use according to claim 3, characterized in that: The inhibitor is 5-(tetradecyloxy)-2-furoic acid.
Citation Information
Patent Citations
TMEM100 gene for regulating energy metabolism of porcine fat cells
CN117551183A
Application of ZBED6 gene in regulation and control of animal fat deposition and fat cell differentiation
CN118028375A
Fat lipid markers of different parts of pig and application of fat lipid markers in regulation and control of pig fat deposition
CN118259023A
Method for suppressing acaca expression
JP2012115374A
Acetyl-coenzyme a carboxylase 2 as a target in the regulation of fat burning, fat accumulation, energy homeostasis and insulin action
US20040204338A1
Cited By
Lipid nanoparticles with RNA for cosmetic treatment
US12685787B2
Use of acetyl-coa carboxylase gene in regulating porcine lipid metabolism
WO2026077470A1
